Recall archive
6 recalls · page 1 of 1
Reported Oct 25, 2023
Bevacizumab 1.25 MG/0.05 ML Solution for Injection, 1 mL syringes, Rx only, Compounded by Pine Pharmaceuticals 355…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Pine Pharmaceuticals, LLC
Matched: Brand · Product · Product details — Lack of Assurance of Sterility
15 more products in this recall
FDA (openFDA drug enforcement)
Reported Apr 19, 2023
Bevacizumab 2.5 mg/0.1 mL, Solution for Injection in 1mL, silicone free slip tip syringe, each Syringe supplied in…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Pine Pharmaceuticals, LLC
Matched: Brand · Product details — Labeling: Incorrect or Missing Lot and/or Exp Date: Lot code on primary packaging is incorrect.
FDA (openFDA drug enforcement)
Reported Jan 11, 2023
Epi-Caine, Epinephrine 0.025% Lidocaine HCL 0.75% Solution for Intraocular Injection, 1 ml, Single Dose Vial,…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Pine Pharmaceuticals, LLC
Matched: Brand · Product details — CGMP Deviations: Raw material recalled by repackager, due to discoloration.
FDA (openFDA drug enforcement)
Reported Sep 21, 2022
Bupivacaine HCl 0.375% w/v and Lidocaine HCl 2% w/v Solution for Retrobulbar or Peribulbar Injection; packaged in a) 10…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Pine Pharmaceuticals, LLC
Matched: Brand · Product details — Lack of Assurance of Sterility
FDA (openFDA drug enforcement)
Reported Mar 28, 2018
Brilliant Blue G for Intraocular Injection 0.5mL vial 0.25 mg/mL Compounded by: Pine Pharmaceuticals 355 Riverwalk Pkwy…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Pine Pharmaceuticals, LLC
Matched: Brand · Product · Product details — Labeling: Label Mix-Up: Brilliant Blue G was labeled with an inaccurate auxiliary label which contained active/inactive ingredient information for…
FDA (openFDA drug enforcement)
Reported Jan 27, 2016
Bevacizumab 1.25 mg/0.05 mL in 3/10 mL 31 G 5/16" Syringe for intravitreal Rx -- Pine Pharmaceuticals, 100 Colvin Woods…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Pine Pharmaceuticals, LLC
Matched: Brand · Product · Product details — Presence of particulate matter: Presence of silicone oil microdroplets in bevacizumab syringes for intravitreal use.
3 more products in this recall
FDA (openFDA drug enforcement)
RecallNow is not a government agency. Every notice above is published by the FDA, USDA FSIS, or CPSC and links back to its source. Back to the look-up